SCHEMBL5004

SCHEMBL5004

O=CC(F)F.[NaH]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL74788 0.95
Water SCHEMBL379637 0.90
Fluoride SCHEMBL28811646 0.90
SCHEMBL28522698 0.90
Formic Acid SCHEMBL31235515 0.82
SCHEMBL11494104 0.76
SCHEMBL17255905 0.73 AKR1B1 (0.45)
SCHEMBL27967099 0.70
SCHEMBL9045911 0.70
SCHEMBL3302057 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118613231-A Orthodontic device for delivering active agents 斯米利奥公司 2024-09-06 CN disclosed
CN-118450890-A Treatment of cancer and autoimmune disorders using nano-polymers of histone deacetylase inhibitors 弗吉尼亚大学专利基金委员会 2024-08-06 CN disclosed
US-20240246934-A1 QUINAZOLINE-BASED COMPOUND, COMPOSITION, AND APPLICATION OF QUINAZOLINE-BASED COMPOUND BEIJING SCITECH-MQ PHARMACEUTICALS LIMITED (CN) 2024-07-25 US disclosed
CN-115109036-B Quinazoline compound, composition and application thereof 北京赛特明强医药科技有限公司 2024-06-11 CN disclosed
CN-118139614-A Sterile liposome-containing compositions and articles 脂肪球有限公司 2024-06-04 CN disclosed
CN-111527065-B Synthetic derivatives of oleoyl-lysophosphatidylinositol (oleoyl-LPI) and uses thereof 科廷大学 2024-05-07 CN disclosed
CN-110678543-B In vitro culture system and method of use thereof 耶达研究及发展有限公司 2024-04-09 CN disclosed
CN-117280030-A Agents, compositions and methods for treating hypoxia and ischemia related conditions 梅兰德制药公司 2023-12-22 CN disclosed
EP-4293016-A1 QUINAZOLINE-BASED COMPOUND, COMPOSITION, AND APPLICATION OF QUINAZOLINE-BASED COMPOUND Beijing Scitech-MQ Pharmaceuticals Limited (CN) 2023-12-20 EP disclosed
CN-110612097-B Liposome drug delivery vehicle 耶达研究及发展有限公司 2023-10-20 CN disclosed
CN-112266386-A 2-chloroadenine derivative, preparation method and application 中山大学 2021-01-26 CN disclosed
EP-2488493-B1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES HOFFMANN LA ROCHE (CH) 2015-04-15 EP disclosed
US-8440710-B2 HSL inhibitors useful in the treatment of diabetes HOFFMANN-LA ROCHE INC. (US) 2013-05-14 US disclosed
EP-2488493-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. Hoffmann-La Roche AG (CH) 2012-08-22 EP disclosed
WO-2011045292-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2011-04-21 WO disclosed
US-20110092512-A1 NEW HSL INHIBITORS USEFUL IN THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2011-04-21 US disclosed
EP-0828710-A1 PROCESS FOR THE PREPARATION OF (THIO-)CARBONIC/CARBAMIC ACID 2-PYRROLIDONYL-3-ESTERS, THIO ESTERS AND AMIDES ZENECA LIMITED (GB) 1998-03-18 EP disclosed
US-5670656-A Process for preparing pyrrolidinones ZENECA LIMITED (GB) 1997-09-23 US disclosed
EP-0763020-A1 SUBSTITUTED PYRROLIDONE, THIAZOLIDONES OR OXAZOLIDONES AS HERBICIDES ZENECA LIMITED (GB) 1997-03-19 EP disclosed
WO-1996037466-A1 PROCESS FOR THE PREPARATION OF (THIO-)CARBONIC/CARBAMIC ACID 2-PYRROLIDONYL-3-ESTERS, THIO ESTERS AND AMIDES ZENECA LIMITED (GB) 1996-11-28 WO disclosed